Cerus Corporation
2550 Stanwell Drive
Concord
California
94520
United States
Tel: 925-288-6000
Website: http://www.cerus.com/
445 articles about Cerus Corporation
-
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
11/8/2021
Cerus Corporation (Nasdaq: CERS) today announced that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in the Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021 at 4:40 p.m. ET.
-
Cerus Corporation Announces Record Third Quarter 2021 Financial Results and Raises Full-Year Product Revenue Guidance
11/2/2021
Cerus Corporation announced financial results for the third quarter ended September 30, 2021.
-
Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
10/19/2021
Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2021 financial results will be released on Tuesday, November 2, 2021, after the close of the stock market.
-
Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply
10/1/2021
Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply
-
Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021
9/20/2021
Cerus Corporation (Nasdaq: CERS) today announced its participation in the Society for the Advancement of Blood Management (SABM) Virtual Annual Meeting, which is scheduled for September 22-25, 2021.
-
Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference
9/15/2021
Cerus Corporation (Nasdaq: CERS) today announced that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in the 2021 Cantor Global Virtual Healthcare Conference on Wednesday, September 29, 2021 at 11:20 a.m. ET.
-
Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors
8/4/2021
Cerus Corporation (Nasdaq: CERS) today announced the appointment of Ann Lucena, CEO of San Ramon Regional Medical Center (SRRMC), to its Board of Directors.
-
Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex
8/3/2021
Cerus Corporation announced that the U.S. Centers for Medicare & Medicaid Services has granted a new technology add-on payment for INTERCEPT Fibrinogen Complex within the Medicare Hospital Inpatient Prospective Payment System.
-
Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021
7/20/2021
Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2021 financial results will be released on Tuesday, August 3, 2021, after the close of the stock market.
-
Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets
7/14/2021
Cerus Corporation (Nasdaq: CERS), a company solely dedicated to safeguarding the global blood supply, and the Transfusion Service of the Swiss Red Cross (Blutspende SRK Schweiz) announced today the tenth anniversary of the use of the INTERCEPT Blood System for its entire platelet supply in Switzerland.
-
Cerus Announces Collaboration with LifeSouth Community Blood Centers to Manufacture INTERCEPT® Fibrinogen Complex
6/30/2021
Cerus Announces Collaboration with LifeSouth Community Blood Centers to Manufacture INTERCEPT ® Fibrinogen Complex
-
Cerus Corporation Celebrates World Blood Donor Day 2021
6/14/2021
Cerus Corporation is proud to announce its celebration of this year’s World Blood Donor Day.
-
Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets
5/17/2021
Cerus Corporation (Nasdaq:CERS) today announced its contract with Canadian Blood Services for the INTERCEPT Blood System for Platelets. Canadian Blood Services is one of Canada’s two blood operators, serving all Canadian provinces and territories except Quebec.
-
Cerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance
5/4/2021
Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2021.
-
Cerus Corporation to Release First Quarter 2021 Financial Results on May 4, 2021
4/20/2021
Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2021 financial results will be released on Tuesday, May 4, 2021, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.
-
Cerus Corporation to Participate in Jefferies Virtual Global Plasma Summit
3/3/2021
Cerus Corporation (Nasdaq: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in the Jefferies Virtual Global Plasma Summit on Thursday, March 11, 2021 at 11:00 am PT/ 2:00 pm ET.
-
Cerus Corporation and Shandong Zhongbaokang Medical Implements Partner to Establish Joint Venture in China
2/24/2021
Joint Venture Will Enable Cerus to Partner with Leader in Transfusion Medicine to Bring INTERCEPT to the Mainland China Transfusion Market
-
Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
2/11/2021
Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full year 2020 financial results will be released on Thursday, February 25, 2021, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview To listen to the
-
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences - Feb 04, 2021
2/4/2021
Cerus Corporation announced that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in two conferences:.
-
Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2020 Product Revenue
1/11/2021
Cerus Corporation (Nasdaq: CERS) announced today preliminary product revenue for the fourth quarter and full year 2020 and provided 2021 product revenue guidance. Cerus’ unaudited preliminary product revenue for the fourth quarter of 2020 totaled $28.2 million, an increase of 35% over the $20.9 million recognized during the same period in the prior year.